Dr. Lee is a NIAAA-funded transplant hepatologist specializing in patient care before and after liver transplant. His research focuses on improving health for patients with alcohol use disorder and alcohol-associated liver disease, through: 1) early liver transplant for alcohol-associated hepatitis; 2) inequities in healthcare access; 3) public policy and advocacy; 4) novel therapeutics and translational studies. His research has resulted in first-author studies published in Annals of Internal Medicine, Lancet Public Health, JAMA Internal Medicine, Gastroenterology, Journal of Hepatology, among others. His research has featured in national media with NBC Nightly News, Today Show, NPR, CNN, Forbes, Los Angeles Times, Wall Street Journal, among others. His research and advocacy has led to changes in National and California transplant and insurance policies, and has incorporated into practice guidelines across North America, Europe, Latin America, and Asia.
Managing AUD and Medical Marijuana Use in Transplant Candidates
The Alliance Conversation Series is a cost-free, fast-paced collaborative opportunity. Through shared insight, multidisciplinary experts identify solutions to critical challenges affecting the community of practice. The Alliance is not an advocacy organization and always intends to maintain an objective and unbiased perspective.
Overview: This session will explore managing AUD and Medical Marijuana use in transplant candidates. We will discuss equity of access to transplant, establishing an AUD program, resources and support needed, and how to advocate for these resources at your center.